New Study Demonstrates CBD’s Strong Safety Profile, Amplifies Calls for FDA Regulation
Observational Data Collected On Long-term Consumption of Oral CBD Shows No Correlation To Safety Issues Raised by FDA
A recently released, comprehensive safety study confirms prior research that orally-ingested cannabidiol (CBD) has a strong safety profile, providing data that addresses FDA’s specific safety concerns regarding CBD, with the results indicating that daily consumption across a range of typical retail products and serving sizes is not associated with elevated liver tests, low testosterone levels, or daytime drowsiness. The results renew calls from the hemp and [Read more]